- Home
- ELEV vs VTVT Comparison
ELEV vs VTVT Comparison
Compare ELEV & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- VTVT
- Stock Information
- Founded
- ELEV 2019
- VTVT 2015
- Country
- ELEV United States
- VTVT United States
- Employees
- ELEV N/A
- VTVT N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- ELEV Health Care
- VTVT Health Care
- Exchange
- ELEV Nasdaq
- VTVT Nasdaq
- Market Cap
- ELEV 22.6M
- VTVT 56.7M
- IPO Year
- ELEV 2021
- VTVT 2015
- Fundamental
- Price
- ELEV $0.38
- VTVT $16.40
- Analyst Decision
- ELEV Hold
- VTVT Strong Buy
- Analyst Count
- ELEV 6
- VTVT 2
- Target Price
- ELEV $1.77
- VTVT $35.50
- AVG Volume (30 Days)
- ELEV 2.4M
- VTVT 7.9K
- Earning Date
- ELEV 08-05-2025
- VTVT 08-07-2025
- Dividend Yield
- ELEV N/A
- VTVT N/A
- EPS Growth
- ELEV N/A
- VTVT N/A
- EPS
- ELEV N/A
- VTVT N/A
- Revenue
- ELEV N/A
- VTVT $17,000.00
- Revenue This Year
- ELEV N/A
- VTVT N/A
- Revenue Next Year
- ELEV N/A
- VTVT N/A
- P/E Ratio
- ELEV N/A
- VTVT N/A
- Revenue Growth
- ELEV N/A
- VTVT N/A
- 52 Week Low
- ELEV $0.22
- VTVT $12.12
- 52 Week High
- ELEV $3.28
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- ELEV 55.33
- VTVT 52.19
- Support Level
- ELEV $0.36
- VTVT $14.83
- Resistance Level
- ELEV $0.39
- VTVT $16.60
- Average True Range (ATR)
- ELEV 0.01
- VTVT 0.71
- MACD
- ELEV -0.00
- VTVT 0.22
- Stochastic Oscillator
- ELEV 53.57
- VTVT 84.14
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.